Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 117
2003 136
2004 157
2005 169
2006 155
2007 109
2008 115
2009 169
2010 212
2011 222
2012 214
2013 198
2014 213
2015 213
2016 273
2017 276
2018 257
2019 231
2020 265
2021 40
Text availability
Article attribute
Article type
Publication date

Search Results

3,636 results
Results by year
Filters applied: . Clear all
Page 1
Applications of machine learning in drug discovery and development.
Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P, Spitzer M, Zhao S. Vamathevan J, et al. Nat Rev Drug Discov. 2019 Jun;18(6):463-477. doi: 10.1038/s41573-019-0024-5. Nat Rev Drug Discov. 2019. PMID: 30976107 Free PMC article. Review.
Delivery technologies for cancer immunotherapy.
Riley RS, June CH, Langer R, Mitchell MJ. Riley RS, et al. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. Nat Rev Drug Discov. 2019. PMID: 30622344 Free PMC article. Review.
Synthetic lethality as an engine for cancer drug target discovery.
Huang A, Garraway LA, Ashworth A, Weber B. Huang A, et al. Nat Rev Drug Discov. 2020 Jan;19(1):23-38. doi: 10.1038/s41573-019-0046-z. Epub 2019 Nov 11. Nat Rev Drug Discov. 2020. PMID: 31712683 Review.
Bispecific antibodies: a mechanistic review of the pipeline.
Labrijn AF, Janmaat ML, Reichert JM, Parren PWHI. Labrijn AF, et al. Nat Rev Drug Discov. 2019 Aug;18(8):585-608. doi: 10.1038/s41573-019-0028-1. Nat Rev Drug Discov. 2019. PMID: 31175342 Review.
The quest to slow ageing through drug discovery.
Partridge L, Fuentealba M, Kennedy BK. Partridge L, et al. Nat Rev Drug Discov. 2020 Aug;19(8):513-532. doi: 10.1038/s41573-020-0067-7. Epub 2020 May 28. Nat Rev Drug Discov. 2020. PMID: 32467649 Review.
Targeted protein degradation: expanding the toolbox.
Schapira M, Calabrese MF, Bullock AN, Crews CM. Schapira M, et al. Nat Rev Drug Discov. 2019 Dec;18(12):949-963. doi: 10.1038/s41573-019-0047-y. Epub 2019 Oct 30. Nat Rev Drug Discov. 2019. PMID: 31666732
Rethinking drug design in the artificial intelligence era.
Schneider P, Walters WP, Plowright AT, Sieroka N, Listgarten J, Goodnow RA Jr, Fisher J, Jansen JM, Duca JS, Rush TS, Zentgraf M, Hill JE, Krutoholow E, Kohler M, Blaney J, Funatsu K, Luebkemann C, Schneider G. Schneider P, et al. Nat Rev Drug Discov. 2020 May;19(5):353-364. doi: 10.1038/s41573-019-0050-3. Epub 2019 Dec 4. Nat Rev Drug Discov. 2020. PMID: 31801986 Review.
The COVID-19 vaccine development landscape.
Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. Thanh Le T, et al. Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5. Nat Rev Drug Discov. 2020. PMID: 32273591 No abstract available.
Therapeutic targeting of trained immunity.
Mulder WJM, Ochando J, Joosten LAB, Fayad ZA, Netea MG. Mulder WJM, et al. Nat Rev Drug Discov. 2019 Jul;18(7):553-566. doi: 10.1038/s41573-019-0025-4. Nat Rev Drug Discov. 2019. PMID: 30967658 Free PMC article. Review.
Next-generation regulatory T cell therapy.
Ferreira LMR, Muller YD, Bluestone JA, Tang Q. Ferreira LMR, et al. Nat Rev Drug Discov. 2019 Oct;18(10):749-769. doi: 10.1038/s41573-019-0041-4. Epub 2019 Sep 20. Nat Rev Drug Discov. 2019. PMID: 31541224 Free PMC article. Review.
3,636 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback